Literature DB >> 1602130

In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis.

D A Neumann1, J R Lane, S M Wulff, G S Allen, A LaFond-Walker, A Herskowitz, N R Rose.   

Abstract

Experimental autoimmune myocarditis (EAM) is elicited in certain strains of mice by immunizing with mouse cardiac myosin. Concomitant with the onset of myocardial inflammation is the induction of circulating IgG antibodies to myosin. To further examine the role of myosin in disease, both EAM-susceptible (A/J) and EAM-resistant (B10.A) mice were immunized with myosin emulsified in CFA and examined for myocardial inflammation and IgG deposition. Myocarditis was common in susceptible, but not resistant strain mice. IgG deposition was extensive in A/J mice, but modest in B10.A mice, when compared to controls given adjuvant alone. Localization was independent of inflammatory or necrotic lesions. A spot ELISA indicated that antimyosin IgG antibody-secreting cells were present in the myocardial infiltrate and likely contributed to antibody localization. Antibody was eluted from the hearts of immunized animals and found to react strongly with normal heart tissue by indirect immunohistochemistry. This reactivity was not completely absorbed by skeletal muscle, indicating that some of the antibody was heart-specific. Western immunostaining demonstrated that eluates from immunized A/J and B10.A mice possessed anti-myosin antibody activity; similar reactivity was not observed in eluates from control mice of either strain. Comparison of heart reactivity with syngeneic and allogeneic tissue suggests that although myosin immunization elicits homologous antibody in both strains, each may recognize distinct epitopes. These findings strongly suggest that cardiac myosin or a myosin-like determinant is expressed on the surface of normal mouse myocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602130

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction.

Authors:  Kun Liu; Liang Shao; Li Wang; Yanping Ding; Guanhua Su; Jue Wang; Yuhua Liao; Zhaohui Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

2.  IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.

Authors:  Nir Grabie; Michael W Delfs; Jason R Westrich; Victoria A Love; George Stavrakis; Ferhaan Ahmad; Christine E Seidman; Jonathan G Seidman; Andrew H Lichtman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

3.  Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.

Authors:  Thomas P Zwaka; Dimitar Manolov; Cüneyt Ozdemir; Nikolaus Marx; Ziya Kaya; Matthias Kochs; Martin Höher; Vinzenz Hombach; Jan Torzewski
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

4.  Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.

Authors:  Adita Mascaro-Blanco; Kathy Alvarez; Xichun Yu; JoAnn Lindenfeld; Leann Olansky; Timothy Lyons; David Duvall; Janet S Heuser; Albina Gosmanova; Carl J Rubenstein; Leslie T Cooper; David C Kem; Madeleine W Cunningham
Journal:  Autoimmunity       Date:  2008-09       Impact factor: 2.815

5.  Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice.

Authors:  John F Elliott; Junliang Liu; Zuan-Ning Yuan; Norma Bautista-Lopez; Sarah L Wallbank; Kunimasa Suzuki; David Rayner; Patrick Nation; Murray A Robertson; Gang Liu; Katherine M Kavanagh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-21       Impact factor: 11.205

6.  FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

Authors:  Ferenc Boldizsar; Oktavia Tarjanyi; Katalin Olasz; Akos Hegyi; Katalin Mikecz; Tibor T Glant; Tibor A Rauch
Journal:  Cardiovasc Pathol       Date:  2016-05-17       Impact factor: 2.185

7.  Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies.

Authors:  C Perez Leiros; N Goren; L Sterin-Borda; L Lustig; E Borda
Journal:  Clin Auton Res       Date:  1994-10       Impact factor: 4.435

8.  Elevated levels of antibodies against sulphatide are present in all chronic chagasic and dilated cardiomyopathy sera.

Authors:  J L Avila; M Rojas; H Carrasco
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

9.  Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis.

Authors:  Lidia Avalle; Francesca Marino; Annalisa Camporeale; Chiara Guglielmi; Daniele Viavattene; Silvio Bandini; Laura Conti; James Cimino; Marco Forni; Cristina Zanini; Alessandra Ghigo; Roman L Bogorad; Federica Cavallo; Paolo Provero; Victor Koteliansky; Valeria Poli
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-22       Impact factor: 6.698

10.  The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules [corrected].

Authors:  J M Penninger; N Neu; E Timms; V A Wallace; D R Koh; K Kishihara; C Pummerer; T W Mak
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.